BACKGROUND
The national rates of readmission and reoperation after open reduction internal fixation (ORIF) of midshaft clavicle fractures in adolescents is unknown.
AIM
To determine rates of and risk factors for readmission and reoperation after ORIF of midshaft clavicle fractures in adolescents.
METHODS
This retrospective study utilized data from the Healthcare Cost and Utilization Project State Inpatient Database for California and Florida and included 11728 patients 10–18 years of age that underwent ORIF of midshaft clavicle fracture between 2005 and 2012. Readmissions within ninety days, reoperations within two years, and differences in patient demographic factors were determined through descriptive, univariate, and multivariate analyses.
RESULTS
In total, 3.29% (
n
= 11) of patients were readmitted within 90 d to a hospital at an average of 18.91 ± 18 d after discharge, while 15.87% (
n
= 53) of patients underwent a reoperation within two years at an average of 209.53 ± 151 d since the index surgery. The most common reason for readmission was a postoperative infection (
n
< 10). Reasons for reoperation included implant removal (
n
= 49) at an average time of 202.39 ± 138 d after surgery, and revision ORIF (
n
< 10) with an average time of 297 ± 289 d after index surgery. The odds of reoperation were higher for females (
P
< 0.01) and outpatients (
P
< 0.01), while the odds of reoperation were lower for patients who underwent surgery in California (
P
= 0.02).
CONCLUSION
There is a low rate of readmission and a high rate of reoperation after ORIF for midshaft clavicle fractures in adolescents. There are significant differences for reoperation based on patient sex, location, and hospital type.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.